MDNCMedinotec Inc.
Health Care
Selling and Marketing Expense revised up 200.0% for Q1 2025
This is the 10th largest revision in MDNC's history.
Selling and Marketing Expense
Q1 2025
As reported
-$21.8KRestated
$21.8K200.0%
Verify against SEC filingsShow
As reported-$21.8K
Accepted 2025-07-160001663577-25-000240
Restated$21.8K
Accepted 2026-07-090001663577-26-000202
SellingAndMarketing · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get an alert the next time MDNC — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.